Suppr超能文献

[β-内啡肽和β-促脂素在肥胖发病机制中的作用]

[Beta-endorphin and beta-lipotropin in the pathogenesis of obesity].

作者信息

Epshteĭn E V

出版信息

Probl Endokrinol (Mosk). 1983 Jan-Feb;29(1):16-9.

PMID:6300830
Abstract

The blood beta-endorphin and beta-lipotropin content was studied by radioimmunoassay in patients with obesity of different degree and healthy subjects with normal body weights. It was shown that the blood beta-endorphin concentration rises depending on the body weight growth, promoting the intensified insulin secretion and obesity development. beta-Lipotropin level was significantly augmented in patients with the 3d and 4th stages of obesity. The intensified beta-lipotropin secretion, stimulating lipolysis, may be considered as a compensatory mechanism, tending to return to normal fat metabolism in the originated pathological conditions. Comparison of beta-endorphin and beta-lipotropin levels in the blood of obese patients suggests that obesity is not only marked by hormonal disorders, producing obesity progression but also by the formation of adaptive mechanisms, directed at compensation of the pathological process.

摘要

采用放射免疫分析法对不同程度肥胖患者及体重正常的健康受试者的血液β-内啡肽和β-促脂解素含量进行了研究。结果显示,血液β-内啡肽浓度随体重增加而升高,促进胰岛素分泌增加及肥胖的发展。肥胖第3和第4阶段患者的β-促脂解素水平显著升高。β-促脂解素分泌增加刺激脂肪分解,可被视为一种代偿机制,旨在使原发病理状态下的脂肪代谢恢复正常。对肥胖患者血液中β-内啡肽和β-促脂解素水平的比较表明,肥胖不仅以导致肥胖进展的激素紊乱为特征,还以针对病理过程代偿的适应性机制形成为特征。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验